Serum untargeted lipidomic profiling reveals dysfunction of phospholipid metabolism in subclinical coronary artery disease
Author(s)
Djekic, Demir
Pinto, Rui
Repsilber, Dirk
Hyotylainen, Tuulia
Henein, Michael
Type
Journal Article
Abstract
Purpose: Disturbed metabolism of cholesterol and triacylglycerols (TGs) carries increased risk for coronary artery calcification (CAC). However, the exact relationship between individual lipid species and CAC remains unclear. The aim of this study was to identify disturbances in lipid profiles involved in the calcification process, in an attempt to propose potential biomarker candidates. Patients and methods: We studied 70 patients at intermediate risk for coronary artery disease who had undergone coronary calcification assessment using computed tomography and Agatston coronary artery calcium score (CACS). Patients were divided into three groups: with no coronary calcification (NCC; CACS: 0; n=26), mild coronary calcification (MCC; CACS: 1-250; n=27), or severe coronary calcification (SCC; CACS: >250; n=17). Patients' serum samples were analyzed using liquid chromatography-mass spectrometry in an untargeted lipidomics approach. Results: We identified 103 lipids within the glycerolipid, glycerophospholipid, sphingolipid, and sterol lipid classes. After false discovery rate correction, phosphatidylcholine (PC)(16:0/20:4) in higher levels and PC(18:2/18:2), PC(36:3), and phosphatidylethanolamine(20:0/18:2) in lower levels were identified as correlates with SCC compared to NCC. There were no significant differences in the levels of individual TGs between the three groups; however, clustering the lipid profiles showed a trend for higher levels of saturated and monounsaturated TGs in SCC compared to NCC. There was also a trend for lower TG(49:2), TG(51:1), TG(54:5), and TG(56:8) levels in SCC compared to MCC. Conclusion: In this study we investigated the lipidome of patients with coronary calcification. Our results suggest that the calcification process may be associated with dysfunction in autophagy. The lipidomic biomarkers revealed in this study may aid in better assessment of patients with subclinical coronary artery disease.
Date Issued
2019-05-13
Date Acceptance
2019-02-18
Citation
Vascular Health and Risk Management, 2019, 15, pp.123-135
ISSN
1176-6344
Publisher
Dove Medical Press
Start Page
123
End Page
135
Journal / Book Title
Vascular Health and Risk Management
Volume
15
Copyright Statement
© 2019 Djekic et al. This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution–Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing thework you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Forpermission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php)
Identifier
https://www.ncbi.nlm.nih.gov/pubmed/31190850
PII: 202344
Subjects
atherosclerosis; autophagy
coronary artery calcification
coronary artery calcium score; lipidomics
lipids
triacylglycerol
Aged
Asymptomatic Diseases
Autophagy
Biomarkers
Chromatography, High Pressure Liquid
Computed Tomography Angiography
Coronary Angiography
Coronary Artery Disease
Dyslipidemias
Female
Humans
Male
Metabolomics
Middle Aged
Multidetector Computed Tomography
Phospholipids
Spectrometry, Mass, Electrospray Ionization
Vascular Calcification
Publication Status
Published
Coverage Spatial
New Zealand